Back to top

Court revives suit against Bristol Myers over delayed drug, Reuters reports

A federal appeals court has revived a $6.7B lawsuit against Bristol Myers (BMY) alleging delayed drug approvals harmed former Celgene shareholders,...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bristol Myers Squibb Company (BMY)

UMB Financial Corporation (UMBF)